What's in Recordati's pipeline?

Recordati has 7 drugs in our index: 7 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Recordati's portfolio?

Top competitors by shared drug class: , Azurity, Baxter, Bayer, Cephalon.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/recordati.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Recordati — Portfolio Competitive Intelligence Brief

Recordati (REC.MI) pipeline: 7 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

REC.MI (Borsa Italiana) 7 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Isturisa	OSILODROSTAT	marketed	Cortisol Synthesis Inhibitor	Cytochrome P450 11B2, mitochondrial	Respiratory	2020-01-01
Signifor	PASIREOTIDE	marketed	Somatostatin Analog [EPC]	Somatostatin receptor type 5	Oncology	2012-01-01
Carbaglu	CARGLUMIC ACID	marketed	Carbamoyl Phosphate Synthetase 1 Activator [EPC]	Carbamoyl-phosphate synthase [ammonia], mitochondrial	Gastroenterology	2010-01-01
Cystadane	BETAINE	marketed	Methylating Agent [EPC]		Infectious Disease	1996-01-01
Cosmegen	DACTINOMYCIN	marketed	Actinomycin [EPC]	DNA	Oncology	1964-01-01
Peganone	ETHOTOIN	marketed	Anti-epileptic Agent	Sodium channel alpha subunit	Neuroscience	1957-01-01
Valchlor	MECHLORETHAMINE	marketed	Alkylating Drug [EPC]		Oncology	1949-01-01

Therapeutic area mix

Oncology · 3
Gastroenterology · 1
Infectious Disease · 1
Neuroscience · 1
Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 2 shared drug classes
Azurity · 2 shared drug classes
Baxter · 1 shared drug class
Bayer · 1 shared drug class
Cephalon · 1 shared drug class
Janssen Prods · 1 shared drug class
Jaymac Pharmaceuticals, LLC · 1 shared drug class
Jazz Pharmaceuticals · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Recordati:

Cite this brief

Drug Landscape (2026). Recordati — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/recordati. Accessed 2026-05-13.